Literature DB >> 10807000

Human Bcl-2 antisense therapy for lymphomas.

F E Cotter1, J Waters, D Cunningham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10807000     DOI: 10.1016/s0167-4781(99)00139-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  12 in total

Review 1.  Targeting the B-cell lymphoma/leukemia 2 family in cancer.

Authors:  Matthew S Davids; Anthony Letai
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

2.  Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.

Authors:  Elizabeth A Brem; Karen Thudium; Sapna Khubchandani; Ping-Chiao Tsai; Scott H Olejniczak; Seema Bhat; Wasif Riaz; Jenny Gu; Arshad Iqbal; Ryan Campagna; Joy Knight; Cory Mavis; Paul Hoskin; George Deeb; John F Gibbs; Gerald Fetterly; Myron S Czuczman; Francisco J Hernandez-Ilizaliturri
Journal:  Br J Haematol       Date:  2011-04-15       Impact factor: 6.998

3.  Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.

Authors:  M Ocker; D Neureiter; M Lueders; S Zopf; M Ganslmayer; E G Hahn; C Herold; D Schuppan
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 4.  Emerging Bcl-2 inhibitors for the treatment of cancer.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Expert Opin Emerg Drugs       Date:  2010-09-03       Impact factor: 4.191

5.  Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.

Authors:  B H Lloyd; R V Giles; D G Spiller; J Grzybowski; D M Tidd; D R Sibson
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

Review 6.  Directing DNA methylation to inhibit gene expression.

Authors:  Andrew R Hoffman; Ji Fan Hu
Journal:  Cell Mol Neurobiol       Date:  2006-05-19       Impact factor: 5.046

Review 7.  Immunodeficient mouse models of lymphoid tumors.

Authors:  Kazunori Imada
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

8.  Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.

Authors:  Jianjun Zhang; Shenglin Huang; He Zhang; Haibo Wang; Haiyan Guo; Guanxiang Qian; Xianqun Fan; Jian Lu; Andrew R Hoffman; Ji-Fan Hu; Shengfang Ge
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

9.  miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer.

Authors:  M Karaayvaz; H Zhai; J Ju
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

10.  Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Authors:  Ashiq Masood; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2011-06-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.